FI944394A - Kinuklidiinijohdannaisia P-aineen antagonisteina - Google Patents
Kinuklidiinijohdannaisia P-aineen antagonisteina Download PDFInfo
- Publication number
- FI944394A FI944394A FI944394A FI944394A FI944394A FI 944394 A FI944394 A FI 944394A FI 944394 A FI944394 A FI 944394A FI 944394 A FI944394 A FI 944394A FI 944394 A FI944394 A FI 944394A
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- substituted
- alkoxy
- hydrogen
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6533792 | 1992-03-23 | ||
PCT/US1993/001810 WO1993019064A1 (fr) | 1992-03-23 | 1993-03-05 | Derives de quinuclidine utiles comme antagonistes de la substance p |
Publications (2)
Publication Number | Publication Date |
---|---|
FI944394A true FI944394A (fi) | 1994-09-22 |
FI944394A0 FI944394A0 (fi) | 1994-09-22 |
Family
ID=13284021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI944394A FI944394A0 (fi) | 1992-03-23 | 1994-09-22 | Kinuklidiinijohdannaisia P-aineen antagonisteina |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0632809B1 (fr) |
JP (1) | JP2656702B2 (fr) |
KR (1) | KR950700908A (fr) |
AT (1) | ATE205207T1 (fr) |
AU (1) | AU3782493A (fr) |
CA (1) | CA2132541C (fr) |
DE (1) | DE69330714T2 (fr) |
DK (1) | DK0632809T3 (fr) |
ES (1) | ES2160596T3 (fr) |
FI (1) | FI944394A0 (fr) |
GR (1) | GR3037025T3 (fr) |
HU (1) | HU9402745D0 (fr) |
IL (1) | IL105098A0 (fr) |
MX (1) | MX9301634A (fr) |
NO (1) | NO943526D0 (fr) |
PT (1) | PT632809E (fr) |
WO (1) | WO1993019064A1 (fr) |
ZA (1) | ZA932016B (fr) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2700472B1 (fr) | 1993-01-19 | 1995-02-17 | Rhone Poulenc Rorer Sa | Association synergisante ayant un effet antagoniste des récepteurs NK1 et NK2. |
IL109646A0 (en) * | 1993-05-19 | 1994-08-26 | Pfizer | Heteroatom substituted alkyl benzylamino-quinuclidines |
US5393762A (en) * | 1993-06-04 | 1995-02-28 | Pfizer Inc. | Pharmaceutical agents for treatment of emesis |
ES2121213T3 (es) * | 1993-07-15 | 1998-11-16 | Pfizer | Benciloxiquinuclidinas como antagonistas de la sustancia p. |
US6083943A (en) * | 1993-09-17 | 2000-07-04 | Pfizer Inc | Substituted azaheterocyclecarboxylic acid |
PT719253E (pt) * | 1993-09-17 | 2004-07-30 | Pfizer | Piperidinas 3-amino-5-carboxi-substituidas e pirrolidinas 3-amino-4-carboxi-substituidas como antagonistas de taquicinina |
EP0653208A3 (fr) * | 1993-11-17 | 1995-10-11 | Pfizer | Antagonistes de la substance P pour le traitement et la prévention de l'erythème solaire. |
EP0659409A3 (fr) * | 1993-11-23 | 1995-08-09 | Pfizer | Antagonistes de la substance P pour l'inhibition de l'angiogénése. |
EP0655246A1 (fr) * | 1993-11-30 | 1995-05-31 | Pfizer Inc. | Antagonistes de la substance P pour le traitement des maladies causées par Helicobacter Pylori ou d'autres bacteries spirales, ureare-positives, gram-négatives |
IL116249A (en) * | 1994-12-12 | 2003-07-06 | Pfizer | Nk-1 receptor antagonists for the treatment of neuronal damage and stroke |
TW458774B (en) | 1995-10-20 | 2001-10-11 | Pfizer | Antiemetic pharmaceutical compositions |
MX9706944A (es) * | 1996-09-12 | 1998-08-30 | Pfizer | Quinuclidinas sustituidas con tetrazolilo como antagonistas de la sustancia p. |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
RU2309953C2 (ru) | 1999-11-03 | 2007-11-10 | Эймр Текнолоджи, Инк. | Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе |
US20040001895A1 (en) * | 2002-06-17 | 2004-01-01 | Pfizer Inc. | Combination treatment for depression and anxiety |
ZA200701232B (en) | 2004-07-15 | 2008-08-27 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
ES2382814T3 (es) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer |
EP1904069B1 (fr) | 2005-07-15 | 2018-06-13 | Albany Molecular Research, Inc. | Tetrahydrobenzazepines substituees par aryle et heteroaryle, et leur utilisation pour bloquer la reabsorption de la noradrenaline, de la dopamine, et de la serotonine |
US8293900B2 (en) | 2005-09-29 | 2012-10-23 | Merck Sharp & Dohme Corp | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2664113C (fr) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Utilisation de la platencine et de la platensimycine en tant qu'inhibiteurs de la synthese des acides gras pour traiter l'obesite, lediabete et le cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
BRPI0806245B1 (pt) | 2007-01-10 | 2022-01-25 | Msd Italia S.R.L. | Compostos de fórmula i e seus usos |
CA2682727C (fr) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Derive d'indoledione |
EP2170076B1 (fr) | 2007-06-27 | 2016-05-18 | Merck Sharp & Dohme Corp. | Dérivés de 4-carboxybenzylamino utilisés en tant qu'inhibiteurs de l'histone désacétylase |
US8598184B2 (en) | 2008-03-03 | 2013-12-03 | Tiger Pharmatech | Protein kinase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
CA2760837C (fr) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline et son utilisation |
KR20120034644A (ko) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도 |
CN102638982B (zh) | 2009-05-12 | 2015-07-08 | 百时美施贵宝公司 | (S)-7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途 |
WO2011046771A1 (fr) | 2009-10-14 | 2011-04-21 | Schering Corporation | Pipéridines substituées qui accroissent l'activité de p53, et utilisations de ces composés |
WO2011163330A1 (fr) | 2010-06-24 | 2011-12-29 | Merck Sharp & Dohme Corp. | Nouveaux composés hétérocycliques utilisés comme inhibiteurs de erk |
CA2805265A1 (fr) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Inhibition a mediation par interference arn de catenine (proteine associee a cadherine), expression du gene beta 1 (ctnnb1) a l'aide de petit acide nucleique interferent (sian) |
WO2012024170A2 (fr) | 2010-08-17 | 2012-02-23 | Merck Sharp & Dohme Corp. | Inhibition médiée par des arn interférents de l'expression génique du virus de l'hépatite b (vhb) à l'aide de petits acides nucléiques interférents (pani) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
EP2615916B1 (fr) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Dérivés condensés de pyrazole utilisés comme nouveaux inhibiteurs erk |
WO2012058210A1 (fr) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | INHIBITION FACILITÉE PAR L'INTERFÉRENCE D'ARN DE L'EXPRESSION D'UN GÈNE AU MOYEN D'ACIDES NUCLÉIQUES INTERFÉRENTS COURTS (siNA) |
WO2012087772A1 (fr) | 2010-12-21 | 2012-06-28 | Schering Corporation | Dérivés d'indazole utiles en tant qu'inhibiteurs de erk |
JP2014514321A (ja) | 2011-04-21 | 2014-06-19 | メルク・シャープ・アンド・ドーム・コーポレーション | インスリン様増殖因子1受容体阻害剤 |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
WO2014052563A2 (fr) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Nouveaux composés inhibiteurs de erk |
MX363243B (es) | 2012-11-28 | 2019-03-14 | Merck Sharp & Dohme | Composiciones para tratar cáncer y usos de dichas composiciones. |
RU2690663C2 (ru) | 2012-12-20 | 2019-06-05 | Мерк Шарп И Доум Корп. | Замещенные имидазопиридины в качестве ингибиторов hdm2 |
US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
WO2020033284A1 (fr) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Inhibiteurs de prmt5 |
EP3833668A4 (fr) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | Inhibiteurs de prmt5 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX18467A (es) * | 1988-11-23 | 1993-07-01 | Pfizer | Agentes terapeuticos de quinuclidinas |
HUT65771A (en) * | 1991-05-22 | 1994-07-28 | Pfizer | Process for producing substituted 3-amino-quinuclidine derivatives and pharmaceutical compositions containing them |
-
1992
- 1992-11-17 JP JP4307179A patent/JP2656702B2/ja not_active Expired - Fee Related
-
1993
- 1993-03-05 DE DE69330714T patent/DE69330714T2/de not_active Expired - Fee Related
- 1993-03-05 EP EP93907099A patent/EP0632809B1/fr not_active Expired - Lifetime
- 1993-03-05 PT PT93907099T patent/PT632809E/pt unknown
- 1993-03-05 AT AT93907099T patent/ATE205207T1/de not_active IP Right Cessation
- 1993-03-05 HU HU9402745A patent/HU9402745D0/hu unknown
- 1993-03-05 WO PCT/US1993/001810 patent/WO1993019064A1/fr active IP Right Grant
- 1993-03-05 ES ES93907099T patent/ES2160596T3/es not_active Expired - Lifetime
- 1993-03-05 CA CA002132541A patent/CA2132541C/fr not_active Expired - Fee Related
- 1993-03-05 DK DK93907099T patent/DK0632809T3/da active
- 1993-03-05 AU AU37824/93A patent/AU3782493A/en not_active Abandoned
- 1993-03-18 IL IL105098A patent/IL105098A0/xx unknown
- 1993-03-22 ZA ZA932016A patent/ZA932016B/xx unknown
- 1993-03-23 MX MX9301634A patent/MX9301634A/es unknown
-
1994
- 1994-09-22 NO NO943526A patent/NO943526D0/no unknown
- 1994-09-22 KR KR1019940703285A patent/KR950700908A/ko not_active Application Discontinuation
- 1994-09-22 FI FI944394A patent/FI944394A0/fi not_active Application Discontinuation
-
2001
- 2001-10-25 GR GR20010401896T patent/GR3037025T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0632809T3 (da) | 2001-11-12 |
NO943526L (no) | 1994-09-22 |
DE69330714T2 (de) | 2002-02-07 |
EP0632809B1 (fr) | 2001-09-05 |
DE69330714D1 (de) | 2001-10-11 |
PT632809E (pt) | 2001-12-28 |
ZA932016B (en) | 1994-09-22 |
ES2160596T3 (es) | 2001-11-16 |
IL105098A0 (en) | 1993-07-08 |
JP2656702B2 (ja) | 1997-09-24 |
FI944394A0 (fi) | 1994-09-22 |
NO943526D0 (no) | 1994-09-22 |
GR3037025T3 (en) | 2002-01-31 |
WO1993019064A1 (fr) | 1993-09-30 |
CA2132541A1 (fr) | 1993-09-30 |
JPH05320162A (ja) | 1993-12-03 |
KR950700908A (ko) | 1995-02-20 |
HU9402745D0 (en) | 1994-12-28 |
EP0632809A1 (fr) | 1995-01-11 |
MX9301634A (es) | 1994-07-29 |
AU3782493A (en) | 1993-10-21 |
ATE205207T1 (de) | 2001-09-15 |
CA2132541C (fr) | 1997-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI944394A (fi) | Kinuklidiinijohdannaisia P-aineen antagonisteina | |
DK0665843T3 (da) | Substituerede quinuclidiner som substans P-antagonister | |
DK568885A (da) | Sure indolforbindelser og deres anvendelse som antiallergiske midler | |
HN1998000074A (es) | Derivados de macrolidos c-4 sustituidos | |
KR910018381A (ko) | 개선된 에르골린-8-카복스아미드 | |
DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
BRPI0507802A (pt) | composto, composição, e, método para tratar inflamação ou um distúrbio metabólico | |
ES2182509T3 (es) | Derivados de n-ariloxietilamina para el tratamiento de la depresion. | |
BR9813665A (pt) | Mistura fungicida, e, processo para o controle de fungos daninhos | |
AR020294A1 (es) | COMPUESTOS DERIVADOS DE 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO, COMPOSICION FARMACEUTICA Y USO EN LA PREPARACIoN DE MEDICAMENTOS. | |
ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. | |
ES2168119T3 (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
DE59103080D1 (de) | 9-Amino-2-phenylbicyclo[3.3.1]nonane und 9-Amino-2-phenylbicyclo[3.3.1]-non-2-ene und diese enthaltende therapeutische Mittel. | |
ES2181791T3 (es) | Derivados de indol para el tratamiento de la migraña. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |